David Shearer, MD
Dermatology · Florence, KYNPI 1659388726
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.1% of the total across 417 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 31 manufacturers reported payments, led by AbbVie at 43.3% of the total.
Across 417 payments — averaging $16.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Johnson & Johnson$1K
- Novartis$568
- Lilly USA, LLC$485
- Regeneron Healthcare Solutions, Inc.$335
- Sun Pharmaceutical Industries Inc.$312
- plus $1K from 25 others
What the payments were for
- Food & beverage$6,61995%
- Education$3435%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 204 | $3,014 |
| Johnson & Johnson | 50 | $1,019 |
| Novartis | 30 | $568 |
| Lilly USA, LLC | 30 | $485 |
| Regeneron Healthcare Solutions, Inc. | 16 | $335 |
| Sun Pharmaceutical Industries Inc. | 15 | $312 |
| UCB, Inc. | 12 | $229 |
| Sanofi | 7 | $127 |
| Amgen | 10 | $122 |
| E.r. Squibb & Sons, L.L.C. | 4 | $81 |
| Helsinn Therapeutics (U.S.), Inc. | 4 | $74 |
| Galderma Laboratories, L.p. | 5 | $73 |
| LEO Pharma Inc. | 4 | $69 |
| Kyowa Kirin, Inc. | 3 | $50 |
| Incyte Corporation | 3 | $42 |
| Medline Industries LP | 1 | $35 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $34 |
| Almirall LLC | 2 | $32 |
| Paratek Pharmaceuticals, Inc. | 2 | $27 |
| Genentech USA, Inc. | 2 | $25 |
| Verrica Pharmaceuticals Inc. | 1 | $24 |
| Blueprint Medicines Corporation | 1 | $24 |
| Krystal Biotech Inc | 1 | $23 |
| VYNE Pharmaceuticals Inc. | 1 | $23 |
| Mylan Institutional Inc. | 1 | $19 |
| Pfizer | 1 | $18 |
| Biofrontera Inc. | 1 | $18 |
| LNHC, Inc | 1 | $16 |
| Icad, Inc | 1 | $15 |
| Merck | 1 | $15 |
| EPI Health, LLC | 1 | $13 |
How this compares
$6,962 in reported general payments places this provider in the 65th percentile of 128 dermatology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 64 | $3,344 |
| Metronidazole | 57 | $3,310 |
| Fluorouracil | 44 | $3,045 |
| Betamethasone Valerate | 105 | $3,009 |
| Ketoconazole | 124 | $2,016 |
| Clobetasol Propionate | 44 | $1,722 |
| ValacyclovirValacyclovir Hcl | 27 | $1,160 |
| Alclometasone Dipropionate | 38 | $1,114 |
| Betamethasone Dipropionate | 17 | $917 |
| Triamcinolone Acetonide | 95 | $826 |
| Minocycline Hcl | 29 | $824 |
| Gentamicin Sulfate | 25 | $797 |
| Doxycycline Hyclate | 45 | $707 |
| Imiquimod | 13 | $673 |
| CiclopiroxCiclopirox Olamine | 30 | $599 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Florence
- Clay ShearerFlorence$10K
- Kristen AhernFlorence$7K
- Clayton ConnerFlorence$6K
- Leon KircikLousiville$4.5M
- Melissa KnucklesCorbin$1.5M
- James WhartonLexington$1.2M
- James JacksonLouisville$326K
- James AllredFranklin$294K
- Jae JungLouisville$188K
- Tanner ParrentHopkinsville$174K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.